Holen Sie sich die Stockscreener-App
23.45
2.01%
-0.48
Handel nachbörslich:
23.45
Schlusskurs vom Vortag:
$23.93
Offen:
$24.12
24-Stunden-Volumen:
225.70K
Relative Volume:
0.61
Marktkapitalisierung:
$438.90M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-67.30M
KGV:
-6.0903
EPS:
-3.8504
Netto-Cashflow:
$-62.65M
1W Leistung:
+9.73%
1M Leistung:
+15.12%
6M Leistung:
-11.71%
1J Leistung:
-8.29%
1-Tages-Spanne:
$22.82
$24.30
1-Wochen-Bereich:
$20.95
$24.65
52-Wochen-Spanne:
$13.70
$27.33
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Firmenname
Tectonic Therapeutic Inc
Sektor
Branche
Telefon
(339) 666-3320
Adresse
490 ARSENAL WAY, WATERTOWN
Compare TECX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
23.45 | 447.88M | 0 | -67.30M | -62.65M | -3.8504 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.83 | 121.97B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.67 | 81.49B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
766.92 | 47.74B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
332.92 | 43.93B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
316.99 | 35.67B | 4.98B | 69.60M | 525.67M | 0.5198 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-09-03 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-21 | Eingeleitet | Mizuho | Outperform |
| 2024-11-20 | Eingeleitet | Raymond James | Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | TD Cowen | Buy |
| 2023-12-18 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-05 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-05-27 | Eingeleitet | Needham | Buy |
| 2021-03-09 | Eingeleitet | Barclays | Overweight |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-11-11 | Eingeleitet | Berenberg | Buy |
| 2020-03-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Mizuho | Buy |
| 2019-04-05 | Eingeleitet | Janney | Buy |
| 2018-10-10 | Eingeleitet | Guggenheim | Buy |
| 2018-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2018-09-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-07-16 | Eingeleitet | Wedbush | Outperform |
| 2018-07-16 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Tectonic Therapeutic Inc Aktie (TECX) Neueste Nachrichten
Tectonic Therapeutics' Q4 Net Loss Widens; Phase 2 APEX Trial Data Due In 2026 - Nasdaq
Tectonic Therapeutic, Inc. Reports Positive Phase 1b Results for TX45 in Pulmonary Hypertension and Advances TX2100 into Phase 1a Trial for Hereditary Hemorrhagic Telangiectasia - Quiver Quantitative
Tenax Therapeutics: Some Future Potential (NASDAQ:TENX) - Seeking Alpha
Tectonic Therapeutic Spotlights TX2100 in HHT as First-in-Human Phase 1 Dosing Begins - Yahoo Finance
Tectonic Therapeutic Announces Leadership Transition and New Chair - TipRanks
Insider Trends: Is now the right time to enter Tectonic Therapeutic IncDollar Strength & Daily Entry Point Alerts - baoquankhu1.vn
Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board - citybiz
Tectonic Therapeutic Appoints François Nader As Chair And Independent Director Of The Board - TradingView
Tectonic Therapeutic Appoints Francois Nader, M.D., as Chair and Independent Director of the Board - Bitget
Aberdeen Group plc Takes $5.59 Million Position in Tectonic Therapeutic, Inc. $TECX - MarketBeat
What are Tectonic Therapeutic Inc.’s technical support levels2025 Winners & Losers & Community Consensus Trade Signals - mfd.ru
Is Tectonic Therapeutic Inc. stock a smart retirement pickJuly 2025 Gainers & Free Community Consensus Stock Picks - mfd.ru
Market Outlook: Will KINS stock hit new highs in YEAREarnings Risk Report & Capital Protection Trading Alerts - baoquankhu1.vn
Published on: 2026-02-16 17:45:36 - baoquankhu1.vn
Can Tectonic Therapeutic Inc. stock double in the next yearLayoff News & Real-Time Stock Entry Alerts - mfd.ru
Daniel Lochner Bought 70% More Shares In Tectonic Therapeutic - Yahoo Finance
Is Tectonic Therapeutic Inc. subject to activist investor interest2025 Biggest Moves & Entry Point Confirmation Signals - mfd.ru
Will Tectonic Therapeutic Inc. benefit from rate cutsJuly 2025 Summary & High Accuracy Investment Entry Signals - mfd.ru
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Here's How Much You Would Have Made Owning Tectonic Therapeutic Stock In The Last 5 Years - Sahm
What are analysts’ price targets for Tectonic Therapeutic Inc.July 2025 Retail & Reliable Entry Point Trade Alerts - mfd.ru
Is Tectonic Therapeutic Inc. stock a falling knife or bargain buy2025 Major Catalysts & AI Optimized Trading Strategy Guides - mfd.ru
Insider Buying: Daniel Lochner Acquires Additional Shares of Tec - GuruFocus
Tectonic Therapeutic (NASDAQ:TECX) CFO Daniel Lochner Purchases 6,000 Shares - MarketBeat
Tectonic Therapeutic to Host Virtual KOL Event and - GlobeNewswire
What are Tectonic Therapeutic Inc.’s recent SEC filings showingQuarterly Market Summary & Accurate Technical Buy Alerts - mfd.ru
What’s the analyst consensus on Tectonic Therapeutic Inc.Portfolio Value Report & Real-Time Stock Entry Alerts - mfd.ru
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Aug Patterns: Is Tectonic Therapeutic Inc subject to activist investor interestWeekly Volume Report & Daily Entry Point Trade Alerts - baoquankhu1.vn
What is Lifesci Capital's Forecast for TECX FY2025 Earnings? - MarketBeat
What is Lifesci Capital’s Forecast for TECX FY2025 Earnings? - Defense World
Risk Hedge: Does Tectonic Therapeutic Inc have declining or rising EPS2025 Valuation Update & Weekly High Conviction Ideas - baoquankhu1.vn
Aug Selloffs: Does Tectonic Therapeutic Inc have declining or rising EPSMarket Growth Summary & Weekly Market Pulse Alerts - baoquankhu1.vn
Lifesci Capital Upgrades Tectonic Therapeutic (NASDAQ:TECX) to “Strong-Buy” - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Upgraded to "Strong-Buy" at Lifesci Capital - MarketBeat
S P Trends: Is Tectonic Therapeutic Inc stock a smart retirement pickExit Point & Daily Profit Focused Screening - baoquankhu1.vn
Aug Sentiment: Can Tectonic Therapeutic Inc. outperform under higher oil prices2025 Dividend Review & AI Based Trade Execution Alerts - baoquankhu1.vn
Aug Retail: Is Tectonic Therapeutic Inc subject to activist investor interestPortfolio Update Summary & Safe Entry Point Identification - baoquankhu1.vn
IPO Launch: What is the PEG ratio of Tectonic Therapeutic Inc2025 Analyst Calls & Long-Term Investment Growth Plans - baoquankhu1.vn
Insiders In Tectonic Therapeutic Still Down 37% On US$51.1m Investment - simplywall.st
Aug Movers: What is STROs market positionJuly 2025 Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Is now the right time to enter Tectonic Therapeutic IncMarket Growth Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 277% Upside Potential in Biotech Innovation - DirectorsTalk Interviews
Breakouts Watch: Is Sprott Focus Trust Inc in a consolidation phase2025 Key Highlights & Real-Time Price Movement Reports - baoquankhu1.vn
Published on: 2026-01-26 00:19:05 - baoquankhu1.vn
Can Tectonic Therapeutic Inc lead its sector in growthQuarterly Trade Report & Verified Entry Point Detection - baoquankhu1.vn
Tectonic Therapeutic Reports Q3 2025 Financial Results - MSN
Stock Report: What is Westwater Resources Incs valuation compared to sectorEarnings Risk Report & Growth Focused Stock Pick Reports - baoquankhu1.vn
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Finanzdaten der Tectonic Therapeutic Inc-Aktie (TECX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.18%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):